US2007270382A1PendingUtilityA1

Composition for Protecting Skin

Assignee: PARK CHANGSEOPriority: Oct 2, 2003Filed: Oct 1, 2004Published: Nov 22, 2007

Est. expiryOct 2, 2023(expired)· nominal 20-yr term from priority

Inventors:Changseo Park Sunki Kim Jinwook Kim Hyeongjoon Kang Bokyung Han Younggon Lee Soyoung Chung Wangkeun Choi Sang-June Nam

A61P 37/08A61P 43/00A61P 17/02A61P 17/12A61Q 17/04A61K 8/68A61P 17/04A61Q 19/00A61P 17/00A61Q 17/00B82Y 5/00A61K 2800/413A61Q 19/08A61K 8/04

PatentIndex Score

Cited by

References

Claims

Abstract

Disclosed are a composition for protecting skin and uses thereof. The composition comprises sphingomyelin as an active ingredient and protects the skin by inhibiting skin aging, treating a skin wound and improving a skin barrier.

Claims

exact text as granted — not AI-modified

1 . A composition for protecting skin comprising sphingomyelin as an active ingredient.  
     
     
         2 . Use of the composition according to  claim 1  for inhibiting a skin aging.  
     
     
         3 . Use of the composition according to  claim 1  for inhibiting a skin photoaging.  
     
     
         4 . Use of the composition according to  claim 1  for curing a wound.  
     
     
         5 . Use of the composition according to  claim 1  for improving a skin barrier function.  
     
     
         6 . The use according to  claim 5 , wherein the use is one for rapidly repairing a damaged skin barrier.  
     
     
         7 . Use of the composition according to  claim 1  for treating an atopic skin.  
     
     
         8 . Use of the composition according to  claim 1  for improving an itchy skin.  
     
     
         9 . Use of the composition according to  claim 1  for improving a softness of skin.  
     
     
         10 . Use of the composition according to  claim 1  for preventing rough and scaly skin formation.  
     
     
         11 . The composition according to  claim 1 , wherein the sphingomyelin is derived from milk or an egg.  
     
     
         12 . The composition according to  claim 1 , wherein the sphingomyelin is hydrogenated sphingomyelin.  
     
     
         13 . The composition according to  claim 1 , wherein the composition is a composition for oral administration or topical application.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.